Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension
- PMID: 2474103
- DOI: 10.1097/00005344-198900133-00003
Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension
Abstract
Dietary sodium restriction alone is effective in lowering blood pressure in some, but not all, patients with essential hypertension. Homeostatic mechanisms, including activation of the renin-aldosterone system, may counteract the effects of sodium restriction. Angiotensin converting enzyme (ACE) inhibitors are also effective as sole therapy in many patients with essential hypertension, but may be less effective in those with low-renin hypertension. The combination of dietary sodium restriction with blockade of the renin system by an ACE inhibitor is a particularly effective way to improve blood pressure control. Addition of a thiazide diuretic will reduce pressure further.
Similar articles
-
Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide.Hypertension. 1991 Jun;17(6 Pt 1):798-803. doi: 10.1161/01.hyp.17.6.798. Hypertension. 1991. PMID: 2045142 Clinical Trial.
-
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.Hypertension. 2007 Feb;49(2):276-84. doi: 10.1161/01.HYP.0000253780.36691.4f. Epub 2006 Dec 11. Hypertension. 2007. PMID: 17159081 Clinical Trial.
-
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.Nephrol Dial Transplant. 1998 Jul;13(7):1682-5. doi: 10.1093/ndt/13.7.1682. Nephrol Dial Transplant. 1998. PMID: 9681711
-
Treating essential hypertension. The first choice is usually a thiazide diuretic.Prescrire Int. 2014 Sep;23(152):215-20. Prescrire Int. 2014. PMID: 25325125 Review.
-
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.Minerva Cardioangiol. 2002 Jun;50(3):169-74. Minerva Cardioangiol. 2002. PMID: 12107398 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous